Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 43,415 | 47,666 | 51,306 | 54,030 | 56,390 |
| Cost of Goods | 32,294 | 34,675 | 37,616 | 37,748 | 38,234 |
| Gross Profit | 11,121 | 12,991 | 13,690 | 16,282 | 18,156 |
| Operating Expenses | 36,017 | 13,772 | 13,921 | 14,435 | 14,480 |
| Operating Income | -24,602 | -106 | 385 | 2,595 | 3,910 |
| Other Income | -537 | 191 | -417 | 439 | 254 |
| Pre-tax Income | -25,139 | 85 | -32 | 3,034 | 4,164 |
| Income Tax | -5,958 | -280 | -211 | 1,092 | 1,023 |
| Net Income Continuous | -19,181 | 365 | 179 | 1,942 | 3,141 |
| Net Income | $-19,181 | $365 | $179 | $1,942 | $3,141 |
| EPS Basic Total Ops | -0.62 | 0.01 | 0.01 | 0.06 | 0.11 |
| EPS Basic Continuous Ops | -0.62 | 0.01 | 0.01 | 0.06 | 0.10 |
| EPS Diluted Total Ops | -0.62 | 0.01 | 0.01 | 0.06 | 0.10 |
| EPS Diluted Continuous Ops | -0.62 | 0.01 | 0.01 | 0.06 | 0.10 |
| EBITDA(a) | $2,757 | $4,086 | $4,532 | $6,926 | $8,461 |